Clinical Trial Update: Patiromer and Diet/hrQoL in Chronic Dialysis [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating patiromer combined with dietary intervention for managing hyperkalemia and improving health-related quality of life in adults with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperkalemia

Drugs mentioned

• Veltassa (patiromer)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Hyperkalaemia, Chronic Kidney Disease Stage 3 and 4 | Phase 3 | Status: RECRUITING